2.41
-0.04 (-1.63%)
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Bearish |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Akoya BioSciences, Inc. | Bearish | Bearish |
Stockmoo Score
Akoya Biosciences Inc is a life sciences technology company. It is delivering spatial biology solutions focused on transforming discovery, clinical research and diagnostics. Its PhenoCycler® (formerly CODEX) and PhenoImager® (formerly Phenoptics) platforms, reagents, software, and services, It offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum from discovery through translational and clinical research and diagnostics. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Small Value |
Ownership
Name | Date | Shares Held |
---|---|---|
Blue Water Life Science Advisors, Lp | 30 Jun 2024 | 4,697,785 |
Peddock Capital Advisors, Llc | 30 Jun 2024 | 234,926 |
52 Weeks Range | ||
Median | 4.00 (65.98%) | |
Total | 1 Buy |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Piper Sandler | 13 Aug 2024 | 4.00 (65.98%) | Buy | 2.28 |
No data within this time range.
Date | Type | Details |
---|---|---|
05 Aug 2024 | Announcement | Akoya Biosciences Reports Second Quarter 2024 Financial Results |
15 Jul 2024 | Announcement | Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2024 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |